Cargando…
Isoliquiritigenin-Induced Differentiation in Mouse Melanoma B16F0 Cell Line
The chemotherapeutical treatment is very limited for malignant melanoma, a highly lethal disease occurs globally. Natural products derived from traditional Chinese medicine licorice are attractive in quest new treatments due to their anti-tumor activities. A new dietary flavonoid isoliquiritigenin (...
Autores principales: | Chen, Xiaoyu, Zhang, Bo, Yuan, Xuan, Yang, Fan, Liu, Jinglei, Zhao, Hong, Liu, Liangliang, Wang, Yanming, Wang, Zhenhua, Zheng, Qiusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529869/ https://www.ncbi.nlm.nih.gov/pubmed/23304254 http://dx.doi.org/10.1155/2012/534934 |
Ejemplares similares
-
Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells
por: Si, Lingling, et al.
Publicado: (2020) -
NADPH Oxidase-Derived Reactive Oxygen Species Are Involved in the HL-60 Cell Monocytic Differentiation Induced by Isoliquiritigenin
por: Chen, Hongmei, et al.
Publicado: (2012) -
Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin-dependent kinase-independent mechanism
por: Si, Lingling, et al.
Publicado: (2017) -
Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin-dependent kinase-independent mechanism
por: Si, Lingling, et al.
Publicado: (2021) -
Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis
por: Gao, Caixia, et al.
Publicado: (2016)